期刊文献+

心房颤动中C反应蛋白增高的临床意义 被引量:1

The Clinical Significance of Elevated C-reactive Protein in Patients with Atrial Fibrillation
下载PDF
导出
摘要 目的:探讨C反应蛋白(CRP)增高在心房颤动(房颤)中的意义。方法:应用免疫法测定76例诊断为房颤患者(房颤组)血清CRP水平,与非房颤患者(对照组)28例比较;并对房颤按时间、病因不同分设组,进行统计学分析。结果:房颤组血清CRP为(4.31±2.88)mg/L,明显高于对照组的(1.15±0.91)mg/L,P<0.05。器质性、孤立性房颤者CRP分别为(5.05±1.91)mg/L,(4.37±1.32)mg/L;持续性、永久性房颤患者CRP分别为(5.60±1.81)mg/L,(5.05±1.59)mg/L,均高于阵发性房颤者的(3.30±1.20)mg/L,P<0.05。结论:CRP增高反映的炎症状态可能促进房颤发生和呈持续性发作。 Objective: To evaluated the effect of CRP increasing in pathogenesis of atrial fibrillation (AF). Methods: The immunochemistry method was used to determine the serum CRP concentration in 76 AF cases. Grouping these patients according to the lasting paroxysm of AF and pathogenetic factor. Results: Serum CRP of patients with AF (4.31±2.88) mg/L was higher than that in control group (1.15±0.91)mg/mL, P 〈 0.05. The CRP of nonfunctional and isolated AF cases were (5.05±1.91) mg/L and (4.37±1.32) mg/L. Serum CRP of persistent and permanent AF patient were (5.60±1.81) mg/L and (5.05±1.59) mg/L respectively, higher than in paroxysmal AF (3.30±l.20)mg/mL, P 〈 0.05. Conclusion: The inflammatory state, reflected by the elevation of serum CRP level, may promote the occurance and persistence of AF.
出处 《岭南急诊医学杂志》 2007年第2期98-99,共2页 Lingnan Journal of Emergency Medicine
关键词 C反应蛋白 心房纤颤 临床意义 atrial fibrillation C-reactive protein clinical significance
  • 相关文献

参考文献2

二级参考文献4

共引文献45

同被引文献15

  • 1臧益民,樊荣.加强多学科协作,争取心血管病研究取得新进展[J].心脏杂志,2006,18(5):483-488. 被引量:24
  • 2Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation[ J]. Cell Mol Life Sci, 2008, 65 (10) : 1489 - 1508.
  • 3Lo LW, Chen SA. Role of atrial remodeling in patients with atrial fibrillation [ J ]. J Chin Med Assoc, 2007, 70 ( 8 ) :303 - 309.
  • 4Thomas H, EverettI V, Ph D, et al. Atrial fibrosis and the methanisms of atrial fibrillation [ J ]. Heart rhythem, 2007, 4 ( 3 suppl) : S24 - S27.
  • 5Kourliouros A, Savelieva I, Kiotsekoglou A, et al. Current concepts in the pathogenesis of atrial fibrillation-[J]. Am Heart J, 2009, 157 (2) :243 -252.
  • 6Chen MC, Chang JP, Liu WH, et al. lncrease.d inflammatory cell infilltration in the atrial myocardium of patients with atrial fibrillation [J]. Am cardiol, 2008, 102(7) :861 -865.
  • 7Liu T, Li G, Li L, et al. Assoeiation belween C-reactive protein and recurrence of atrial fibrillation after successful eleetrleal eardioversion : ameta-analysis [J].Jam Coll Cardiol, 2007, 49 ( 15 ) : 1642 - 1648.
  • 8Marcus GM, Whooley MA, Glidden DV, et al. lnterlcukin-6 and atrial fibrillation in patients with coronary disease: date from the Heart and Soul Study[J]. Am Heart J, 2008, 155(2) :303 -309.
  • 9Smit MD, Van Gelder IC. Is inflammation a risk factor for recurrent atrial fibrillation7 [ J ]. Europace, 2009, 11 (2) : 138 - 139.
  • 10Sawaya SE, Rajawat YS, Rami TG, et al. Downregulatinn of connexin40 and increased prevalence of atrial arrhythmias in transgenie mice with cardiac-restricted overexpression of tumor neurosis factor [J]. Am J Physiol Heart CircPhysiol, 2007, 292 (3) : H1561 - H1567.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部